PMC5598352

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children receiving glutamine had significantly improved sensory neuropathy scores compared to placebo on the NCI-CTCv3, with the glutamine group having 3.48 times higher odds of a drop in sensory neur

Effect: improvement; OR 3.48 (glutamine group had 3.48 times higher odds of sensory neuropathy score reduction)

Children in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit

Effect: improvement; 8.42 points higher on PedsQL total score

Children in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit

Effect: improvement; 8.42 points higher on PedsQL total score

Children in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit

Effect: improvement; 8.42 points higher on PedsQL total score

Children in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit

Effect: improvement; 8.42 points higher on PedsQL total score

Children in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit

Effect: improvement; 8.42 points higher on PedsQL total score

Children in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit

Effect: improvement; 8.42 points higher on PedsQL total score

Children in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit

Effect: improvement; 8.42 points higher on PedsQL total score

Children in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit

Effect: improvement; 8.42 points higher on PedsQL total score

Children in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit

Effect: improvement; 8.42 points higher on PedsQL total score

Children in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit

Effect: improvement; 8.42 points higher on PedsQL total score

Children in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit

Effect: improvement; 8.42 points higher on PedsQL total score

Children in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit

Effect: improvement; 8.42 points higher on PedsQL total score

Children in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit

Effect: improvement; 8.42 points higher on PedsQL total score

Children in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit

Effect: improvement; 8.42 points higher on PedsQL total score

Children in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit

Effect: improvement; 8.42 points higher on PedsQL total score

Children in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit

Effect: improvement; 8.42 points higher on PedsQL total score

Children in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit

Effect: improvement; 8.42 points higher on PedsQL total score

Children in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit

Effect: improvement; 8.42 points higher on PedsQL total score

Children in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit

Effect: improvement; 8.42 points higher on PedsQL total score

Children in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit

Effect: improvement; 8.42 points higher on PedsQL total score

Children in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit

Effect: improvement; 8.42 points higher on PedsQL total score

Children in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit

Effect: improvement; 8.42 points higher on PedsQL total score

Children in the glutamine group scored 8.42 points higher than the placebo group on the PedsQL 4.0 total quality of life summary score at time 3, reflecting self-reported improvement in overall qualit

Effect: improvement; 8.42 points higher on PedsQL total score